Bonine Tablet, Chewable
NDC Package 65197-296-08
Package Information
Bonine (meclizine hydrochloride) tablets is dosage should be taken one hour before travel startsadults and children 12 years of age and over: take 1 to 2 tablets once daily or as directed by a doctor. This formulation utilizes a tablet, chewable delivery system. Marketed by Wellspring Pharmaceutical Corporation, this product is identified by NDC 65197-296 and is authorized under FDA application M009.
Identification & Billing
- RxCUI: 995632 - meclizine HCl 25 MG Chewable Tablet
- RxCUI: 995632 - meclizine hydrochloride 25 MG Chewable Tablet
- RxCUI: 995634 - Bonine 25 MG Chewable Tablet
- RxCUI: 995634 - meclizine hydrochloride 25 MG Chewable Tablet [Bonine]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65197 - Wellspring Pharmaceutical Corporation
- 65197-296 - Bonine
- 65197-296-08 - 1 BLISTER PACK in 1 BOX / 8 TABLET, CHEWABLE in 1 BLISTER PACK
- 65197-296 - Bonine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (65197-296). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65197-296-08 identifies a specific commercial package of 1 blister pack in 1 box / 8 tablet, chewable in 1 blister pack of Bonine, a human over the counter drug labeled by Wellspring Pharmaceutical Corporation. This tablet, chewable is formulated for oral use and contains meclizine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wellspring Pharmaceutical Corporation on February 15, 2023.
How is this Wellspring Pharmaceutical Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65197029608. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.